26.5M
XNAS Volume
High volume today
XNAS 21 Mar, 2025 5:30 PM (EDT)
Policy Headwinds
Gilead falls on Wednesday as Trump administration puts HIV prevention funds under review
See details
Medium Financial Strength
Expensive Valuation
Technically Moderately Bullish
Expensive Rocket
These stocks are a favourite among investors due to their bullish nature, good technical aspects but they have bad valuation and medium financials.
View Similar
Embed DVM
Gilead Sciences, Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..